Io Therapeutics, Inc

Io Therapeutics Inc. is a privately held biopharmaceutical company based in Houston, Texas, focused on the discovery and development of therapeutic compounds that target nuclear receptors for conditions such as cancer, neurodegenerative diseases, and autoimmune disorders. The company specializes in the development of retinoid and rexinoid drugs that influence gene expression through their interaction with nuclear receptors.

Through its innovative research on retinoic acid receptors and retinoic acid X receptors, Io Therapeutics aims to advance the understanding of cancer biology and the pathophysiology associated with neurological conditions like Alzheimer's and Parkinson's diseases, as well as the regulation of the immune system in autoimmune diseases. The company's commitment to developing targeted therapies positions it at the forefront of biopharmaceutical advancements.

Generated from the website